Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up

Table 3

Drug dosing recommendations for tenofovir in CHB patients with CKD.

eGFR (mL/Min)	Dosage recommended
≥90	300 mg/day
<90–50	300 mg/day
<50–30	300 mg every 48 hours
<30–15	300 mg every 72 to 96 hours; or 300 mg twice a week
<15	300 mg once a week
HD^*	300 mg once a week
CAPD	ND

 ^*In hemodialysis patients, tenofovir should be administered on a hemodialysis day, after the session.
eGFR: estimated glomerular filtration rate; ND: no data.
Source: http://www.sitegpr.com/.